SinoFresh®Receives Letter of Credit from Magnate Premier Ltd. for $10,000,000 (Ten Million) in Funding
Summary
SinoFresh(TM) Nasal and Sinus Care product achieved efficacy in animal models against Methicillin Resistant Staphylococcus aureus, (MRSA), in live noses.Charles Fust, CEO of SinoFresh, expressed cautious optimism by stating, "There are significant details that have to be worked out with regard to use of proceeds, debt restructuring and the development of scientific initiatives we will be targeting.The companys lead product, SinoFresh(TM) Nasal and Sinus Care is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants is available nationwide.The antibiotic Mupirocin is currently used to reduce nasal MRSA loads.Charles Fust, CEO of SinoFresh, expressed cautious optimism by stating, "There are significant details that have to be worked out with regard to use of proceeds, debt restructuring and the development of scientific initiatives we will be targeting.The companys lead product, SinoFresh(TM) Nasal and Sinus Care is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants is available nationwide.